You are here

Eli Lilly

Eli Lilly, Boehringer Ingelheim's Jardiance clinches heart failure edge with FDA nod for wider label

Fierce Pharma

Fri, 02/25/22 - 10:24 am

Boehringer Ingelheim

Eli Lilly plans $700 million Institute for Genetic Medicine in Boston Seaport

WCVB.com

Tue, 02/22/22 - 10:53 am

genetic medicine

Lilly unveils mirikizumab data in ulcerative colitis as it preps filings

Pharmaforum

Mon, 02/21/22 - 10:36 am

ulcerative colitis

clinical trials

Lilly reunites with ImmunoGen to expand into ADCs, paying $13M upfront and $1.7B on the back end

Fierce Biotech

Tue, 02/15/22 - 10:35 am

antibody-drug conjugate

Eli Lilly and Roche ask CMS not to be lumped in with Aduhelm’s restrictive judgment

Endpoints

Mon, 02/14/22 - 11:06 am

Alzheimer's disease

The biggest launches of 2022: a reboot

EP Vantage

Mon, 02/14/22 - 10:48 am

Mirati Therapeutics

Bristol Myers Squibb

deucravacitinib

Lilly back in COVID-19 antibody game with $720 million deal with U.S. for omicron-busting hopeful

Fierce Pharma

Fri, 02/11/22 - 11:48 am

monoclonal antibodies

FDA sends signal with tough questions of Lilly at cancer drug meeting

BioPharma Dive

Thu, 02/10/22 - 10:37 pm

Innovent Biologics

clinical trials

Neuro-focused Arkuda raises $64M as dementia drug moves closer to the clinic

MedCity News

Thu, 02/10/22 - 10:22 am

Arkuda Therapeutics

Eli Lilly, Innovent's PD-1 in troubled waters as FDA review, oncology chief's comments portend likely rejection

Fierce Pharma

Wed, 02/9/22 - 10:56 am

PD-1 inhibitors

COVID-19 treatments earned 4 drugmakers $14B in 2021

Beckers Hospital Review

Tue, 02/8/22 - 11:50 pm

Gilead Sciences

Endeavor Bio adds $101M to test ex-Eli Lilly, Roche drug in cancer & lung fibrosis

MedCity News

Tue, 02/8/22 - 09:52 am

Endeavor BioMedicines

idiopathic pulmonary fibrosis

Lilly slows FDA submission of Alzheimer's drug after Medicare decision

BioPharma Dive

Thu, 02/3/22 - 11:43 pm

Alzheimer's disease

Eli Lilly (LLY) Q4 Earnings Miss, COVID Therapies Aid Sales

Yahoo/Zacks.com

Thu, 02/3/22 - 11:41 pm

Eli Lilly Announces Nearly $1.5 Billion Investment into New Manufacturing Facilities in North Carolina and Ireland

Xtalks

Thu, 02/3/22 - 10:57 am

drug manufacturing

CMS' Biogen decision could spell problems for Lilly, Roche Alzheimer's drugs, half of surveyed neurologists say

Fierce Pharma

Tue, 02/1/22 - 10:50 am

Alzheimer's disease

Eli Lilly, Incyte axe Olumiant in lupus amid eczema stalemate at FDA

Fierce Pharma

Fri, 01/28/22 - 11:47 am

Eli Lilly plans €400m Irish plant that will create 800 jobs

Pharmaforum

Fri, 01/28/22 - 10:13 am

drug manufacturing

FDA bans use of Lilly, Regeneron COVID drugs due to Omicron

Pharmaforum

Tue, 01/25/22 - 10:44 am

Omicron COVID-19 variant

Trulicity Instagram post draws OPDP’s first untitled letter of 2022

RAPS.org

Mon, 01/24/22 - 11:37 pm

Pages